Clinical Services

Offering early phase clinical research and custom clinical services at our Glasgow Royal Infirmary facility. Make critical decisions earlier with our expert support.

Are you planning a clinical study?

Tailored solutions

We recognise that different partners have unique needs, and our clinical services are tailored to suit Sponsor requirements.

BDD has proven expertise in early phase clinical research and has supported the pharmaceutical and biotech industries in understanding in vivo product performance for over 20 years.

Our bespoke clinical services are provided in our custom designed clinical facility located within the grounds of Glasgow Royal Infirmary.

We can do as much or as little as you need, from simply acting as a clinical site to providing a full Contract Research Organisation (CRO) service. We provide the following early phase clinical trial services:

  • First-in-Human (FIH)
  • Single Ascending Dose (SAD) and Multi Ascending Dose (MAD)
  • Pharmacokinetic
  • Pharmacodynamics
  • Bioavailability
  • Food Effect trials
  • Bioequivalence
  • Proof of Concept (POC)
  • Combined and Adaptive (SWIFT) trials
  • Scintigraphic studies
  • Pilot Studies

We can also support the continued progression of your clinical development programme through Phase II to IV in partnership with the NHS and partner company CPS Research.

Clinical Capabilities

BDD’s independent clinical facility was established in 2000 and is situated within the Glasgow Royal Infirmary, Scotland, UK.

The facility is covered by the hospital medical emergency team 24 hours a day, 7 days a week. The unit comprises 2 ward areas for clinical monitoring and overnight stays, a volunteer kitchen and recreational area, a gamma camera imaging suite, laboratory and consulting rooms. Emergency alarms are situated throughout the unit.

The facility includes an integrated MHRA (Medicines and Healthcare Regulatory products Agency) accredited good manufacturing practice (GMP) manufacturing suite/radiopharmacy enabling IMPs (Investigational Medicinal Products) to be manufactured and QP (Qualified Person) released onsite for dosing to trial participants in as little as 4 hours; temperature-controlled storage and a Home-Office licence to possess and supply controlled drugs.

Our experienced and adaptable team of physicians, nurses, clinical trial associates and pharmacists ensure the safe and efficient running of your study. All physicians are ALS (Advanced Life Support) trained and non-medical clinical staff are trained by the hospital resuscitation team to ILS level or equivalent. BDD Pharma clinical staff undergo regular emergency scenario training, providing you with the assurance that your trial subjects are in the safest of hands.

We provide a range of clinical procedures including:

  • pharmacokinetic blood sampling
  • safety monitoring
  • ECG assessment
  • continuous medical monitoring including telemetry
  • pH ambulatory monitoring
  • Spirometry
  • gamma scintigraphic imaging
  • X-Rays
  • fluoroscopy


All our clinical activities are overseen by our Research and Medical Director – Dr Lyn Corry MBChB MRCP who joined the team in 2016.

Lyn has expertise in clinical study design and implementation and has been involved in clinical research throughout her career with roles including Principal Investigator, Co-investigator, and Medical Monitor for Phase I-III studies.

She is a highly experienced clinician having worked for 19 years within the NHS including 9 years as a Consultant Gastroenterologist before joining the BDD Pharma team full time.   Lyn has an MBChB from the University of Glasgow and is a member of the Royal College of Physicians (MRCP) and Affiliate member of the Faculty of Pharmaceutical Medicine. She has numerous first and co-author publications in high-ranking peer reviewed journals and has given multiple international and national invited presentations at large medical conferences. She is also an Honorary Clinical Senior Lecturer in the College of Medical, Veterinary and Life Sciences, University of Glasgow.